Agency for Science, Technology and Research
A*STAR
The Agency for Science, Technology and Research (A*STAR) is a Singapore-based public research agency that operates as both a scientific research organization and a venture investor. Per a 2021 Gaorong Ventures piece, it incubated Mirxes in 2010, spinning out a microRNA clinical biomarker R&D center to commercialize PCR detection technology for cancer early screening . It subsequently invested in Mirxes's $50 million Series D in mid-2023 alongside EDBI, Mitsui & Co., and others . The bundle does not contain further details on A*STAR's overall mandate, scale, or other portfolio holdings.
AI-generated — may contain errors, please verify.
Coverage
Healthcare and chip companies close new funding rounds; satellite communications, energy storage batteries, and other sectors hit milestones | Rongbao · July
Foresight and courage.
Mirxes Completes $50 Million Series D to Accelerate Cancer Early-Screening Pipeline R&D and Commercialization
Focused on innovative blood-based early screening products and services for cancer.
"Tiny but Mighty" miRNA: How Cancer Can Be Caught at Its Earliest Stage | Gaorong Ventures "Future"
By applying microRNA to early cancer screening, we can transform cancer from a terminal illness into a chronic disease that can be intercepted at an early stage.
